1. Home
  2. XERS vs FAX Comparison

XERS vs FAX Comparison

Compare XERS & FAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • FAX
  • Stock Information
  • Founded
  • XERS 2005
  • FAX 1986
  • Country
  • XERS United States
  • FAX United States
  • Employees
  • XERS N/A
  • FAX N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • FAX Investment Managers
  • Sector
  • XERS Health Care
  • FAX Finance
  • Exchange
  • XERS Nasdaq
  • FAX Nasdaq
  • Market Cap
  • XERS 628.7M
  • FAX 645.2M
  • IPO Year
  • XERS 2018
  • FAX N/A
  • Fundamental
  • Price
  • XERS $4.51
  • FAX $15.79
  • Analyst Decision
  • XERS Strong Buy
  • FAX
  • Analyst Count
  • XERS 6
  • FAX 0
  • Target Price
  • XERS $6.25
  • FAX N/A
  • AVG Volume (30 Days)
  • XERS 2.1M
  • FAX 833.6K
  • Earning Date
  • XERS 08-07-2025
  • FAX 01-01-0001
  • Dividend Yield
  • XERS N/A
  • FAX 12.09%
  • EPS Growth
  • XERS N/A
  • FAX N/A
  • EPS
  • XERS N/A
  • FAX N/A
  • Revenue
  • XERS $222,551,000.00
  • FAX N/A
  • Revenue This Year
  • XERS $35.03
  • FAX N/A
  • Revenue Next Year
  • XERS $18.31
  • FAX N/A
  • P/E Ratio
  • XERS N/A
  • FAX N/A
  • Revenue Growth
  • XERS 29.88
  • FAX N/A
  • 52 Week Low
  • XERS $2.03
  • FAX $2.33
  • 52 Week High
  • XERS $6.07
  • FAX $2.84
  • Technical
  • Relative Strength Index (RSI)
  • XERS 46.97
  • FAX 55.84
  • Support Level
  • XERS $4.30
  • FAX $15.66
  • Resistance Level
  • XERS $4.79
  • FAX $15.96
  • Average True Range (ATR)
  • XERS 0.23
  • FAX 0.12
  • MACD
  • XERS -0.01
  • FAX 0.00
  • Stochastic Oscillator
  • XERS 25.93
  • FAX 61.96

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About FAX abrdn Asia-Pacific Income Fund Inc.

Aberdeen Asia-pacific Income Fund Inc is a United States-based closed-end, non-diversified management investment company. Its principal investment objective is to seek current income along with capital appreciation. The fund invests in Asian debt securities, Australian debt securities, European debt securities and others.

Share on Social Networks: